203 related articles for article (PubMed ID: 17432211)
1. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
Hatakeyama S
Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms to control degradation of polyglutamine-containing protein].
Nakayama K
Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
[TBL] [Abstract][Full Text] [Related]
3. Molecular clearance of ataxin-3 is regulated by a mammalian E4.
Matsumoto M; Yada M; Hatakeyama S; Ishimoto H; Tanimura T; Tsuji S; Kakizuka A; Kitagawa M; Nakayama KI
EMBO J; 2004 Feb; 23(3):659-69. PubMed ID: 14749733
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
5. Roles of VCP in human neurodegenerative disorders.
Kakizuka A
Biochem Soc Trans; 2008 Feb; 36(Pt 1):105-8. PubMed ID: 18208395
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
Tai HC; Schuman EM
Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
8. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
9. Enhanced SUMOylation in polyglutamine diseases.
Ueda H; Goto J; Hashida H; Lin X; Oyanagi K; Kawano H; Zoghbi HY; Kanazawa I; Okazawa H
Biochem Biophys Res Commun; 2002 Apr; 293(1):307-13. PubMed ID: 12054600
[TBL] [Abstract][Full Text] [Related]
10. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
Ardley HC; Hung CC; Robinson PA
FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes that modify ataxin-1-induced neurodegeneration.
Fernandez-Funez P; Nino-Rosales ML; de Gouyon B; She WC; Luchak JM; Martinez P; Turiegano E; Benito J; Capovilla M; Skinner PJ; McCall A; Canal I; Orr HT; Zoghbi HY; Botas J
Nature; 2000 Nov; 408(6808):101-6. PubMed ID: 11081516
[TBL] [Abstract][Full Text] [Related]
12. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
[TBL] [Abstract][Full Text] [Related]
13. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration.
Higashiyama H; Hirose F; Yamaguchi M; Inoue YH; Fujikake N; Matsukage A; Kakizuka A
Cell Death Differ; 2002 Mar; 9(3):264-73. PubMed ID: 11859409
[TBL] [Abstract][Full Text] [Related]
14. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
[TBL] [Abstract][Full Text] [Related]
15. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
16. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
Ristic G; Sutton JR; Libohova K; Todi SV
Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
[TBL] [Abstract][Full Text] [Related]
19. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
Michalik A; Van Broeckhoven C
Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
[TBL] [Abstract][Full Text] [Related]
20. Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.
Ghosh B; Karmakar S; Prasad M; Mandal AK
Mol Biol Cell; 2021 Aug; 32(17):1579-1593. PubMed ID: 34161122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
